Skip to main content
Glenmark Pharmaceuticals ltd logo

Glenmark Pharmaceuticals ltd — Investor Relations & Filings

Ticker · GLENMARK ISIN · INE935A01035 LEI · 335800WKECZXIIT9GK20 BSE.NS Manufacturing
Open in API
Filings indexed 1,049 across all filing types
Latest filing 2020-11-06 Regulatory Filings
Country IN India
Listing BSE.NS GLENMARK

About Glenmark Pharmaceuticals ltd

https://glenmarkpharma.com/

Glenmark Pharmaceuticals Ltd. is a research-driven global organization focused on the development, manufacturing, and marketing of generic, specialty, and over-the-counter medicines. The company maintains a specialized focus on therapeutic areas including dermatology, respiratory health, and oncology. It operates a robust research and development pipeline featuring New Chemical Entities (NCEs) and New Biological Entities (NBEs), supported by multiple global R&D centers. Its commercial footprint extends across North America, Europe, and emerging markets. The company is distinguished by its expertise in complex generics and its integrated approach to drug discovery and formulation development. Glenmark utilizes a network of advanced manufacturing facilities to deliver high-quality healthcare solutions globally, emphasizing innovation and accessibility in its product portfolio.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2020-11-06 English
Copy of Newspaper Publication
Board/Management Information Classification · 95% confidence The document contains a notice of a Board Meeting published in newspapers, addressed to stock exchanges and regulatory bodies, referencing compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a formal announcement about the scheduling of a Board Meeting rather than the meeting materials or minutes themselves. The document also includes legal summons and other unrelated notices, but the primary corporate filing content is the notice of the Board Meeting publication. The document length is about 15,000 characters, but the core filing content is the notice of the Board Meeting publication, which fits the category of Board/Management Information (MANG) as it relates to corporate governance events like board meetings. It is not an Annual Report, Audit Report, or Earnings Release, nor is it a report publication announcement since it does not mention the release of a report but rather the notice of a board meeting. Therefore, the best classification is MANG with high confidence.
2020-10-28 English
Cessation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the cessation of a director's term on the company's board. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events related to changes in the board or management. The content clearly states that Mr. Milind Sarwate ceases to be a director due to the completion of his term and his inability to continue. There is no financial data, earnings information, or report publication mentioned. The document is an announcement of a change in the company's board of directors, fitting the category of Board/Management Information (MANG). The document length is 3801 characters, which is consistent with a detailed announcement rather than a full report.
2020-10-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is an invitation letter for an earnings call scheduled on November 9, 2020, for Glenmark Pharmaceuticals' Q2 FY 2020-21 results. It includes dial-in numbers and contact details for clarifications. The document does not contain any financial data or results itself but is an announcement of the upcoming earnings call event. Therefore, it is classified as a Call Transcript (CT) type document, specifically an invitation to a call rather than the transcript itself. However, since the document is an invitation to the earnings call, it fits best under the Call Transcript (CT) category as it relates directly to the earnings call event.
2020-10-28 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a forthcoming Board Meeting scheduled for November 6, 2020, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2020. It also mentions the closure of the trading window for insider trading compliance. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is an announcement of a board meeting and related compliance information, not the actual financial report or results. The document length is only 1995 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-10-27 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a scheduled Board Meeting to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2020. It references regulatory compliance under SEBI regulations and insider trading code but does not contain any financial data or the results themselves. The document length is only 1995 characters, indicating it is an announcement rather than a full report. Therefore, it is a Regulatory Filing (RNS) as it is a general regulatory announcement about an upcoming board meeting and financial results approval, not the financial report itself.
2020-10-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.